RT Journal Article
T1 Differential Proinflammatory Signature in Vestibular Migraine and Meniere Disease.
A1 Flook, Marisa
A1 Frejo, Lidia
A1 Gallego-Martinez, Alvaro
A1 Martin-Sanz, Eduardo
A1 Rossi-Izquierdo, Marcos
A1 Amor-Dorado, Juan Carlos
A1 Soto-Varela, Andres
A1 Santos-Perez, Sofia
A1 Batuecas-Caletrio, Angel
A1 Espinosa-Sanchez, Juan Manuel
A1 Pérez-Carpena, Patricia
A1 Martinez-Martinez, Marta
A1 Aran, Ismael
A1 Lopez-Escamez, Jose Antonio
K1 CCL22
K1 CCL3
K1 CXCL1
K1 IL-1β
K1 Meniere Disease
K1 Vestibular Migraine
K1 differential diagnosis
AB Vestibular Migraine (VM) and Meniere's Disease (MD) are episodic vestibular syndromes defined by a set of associated symptoms such as tinnitus, hearing loss or migraine features during the attacks. Both conditions may show symptom overlap and there is no biological marker to distinguish them. Two subgroups of MD patients have been reported, according to their IL-1β profile. Therefore, considering the clinical similarity between VM and MD, we aimed to investigate the cytokine profile of MD and VM as a means to distinguish these patients. We have also carried out gene expression microarrays and measured the levels of 14 cytokines and 11 chemokines in 129 MD patients, 82 VM patients, and 66 healthy controls. Gene expression profile in peripheral blood mononuclear cells (PBMC) showed significant differences in MD patients with high and low basal levels of IL- 1β and VM patients. MD patients with high basal levels of IL- 1β (MDH) had overall higher levels of cytokines/chemokines when compared to the other subsets. CCL4 levels were significantly different between MDH, MD with low basal levels of IL- 1β (MDL), VM and controls. Logistic regression identified IL- 1β, CCL3, CCL22, and CXCL1 levels as capable of differentiating VM patients from MD patients (area under the curve = 0.995), suggesting a high diagnostic value in patients with symptoms overlap.
YR 2019
FD 2019-06-04
LK http://hdl.handle.net/10668/14137
UL http://hdl.handle.net/10668/14137
LA en
DS RISalud
RD Apr 14, 2025